The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: Results of a GALEN meta-analysis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 64, Issue 11, 2009, Pages 1570-1579

  Compalati, E ^a   Passalacqua, G ^a   Bonini, M ^a   Canonica, G W ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Efficacy; House dust mites; Meta analysis; Specific immunotherapy

Indexed keywords

HOUSE DUST ALLERGEN; PLACEBO;

ALLERGIC RHINITIS; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DERMATOPHAGOIDES; DRUG EFFICACY; HOUSE DUST ALLERGY; HUMAN; IMMUNOTHERAPY; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SENSITIVITY ANALYSIS; SENSITIZATION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; ANIMALS; ASTHMA; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; HUMANS; PYROGLYPHIDAE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY HYPERSENSITIVITY; RHINITIS, ALLERGIC, PERENNIAL; TREATMENT OUTCOME;

EID: 70349852928     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02129.x     Document Type: Review

References (34)

1. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ 1999 318 : 593 596.
2. Jørgensen AW, Hilden J, Gøtzsche PC. Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review. BMJ 2006 333 : 782. Epub 2006 Oct 6. Review.
3. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008 63 : 8 160 (Review).
4. Penagos M, Compalati E, Tarantini F, Baena-Cagnani R, Huerta J, Passalacqua G et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006 97 : 141 148.
5. Penagos M, Passalacqua G, Compalati E, Baena-Cagnani CE, Orozco S, Pedroza A et al. Meta-analysis of the efficacy of sublingual immunotherapy in allergic asthma in pediatric patients, 3 to 18 years of age. Chest 2008 133 : 599 609.
6. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005 60 : 4 12.
7. Calamita Z, Saconato H, Pela AB, Atallah AN. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane collaboration method. Allergy 2006 61 : 1162 1172.
8. Olaguibel JM, Alvarez Puebla MJ. Efficacy of sublingual allergen vaccination forrespiratory allergy in children. Conclusions from one meta-analysis. J Investig Allergol Clin Immunol 2005 15 : 9 16.
9. Dawson B. Research questions about one group. In : Dawson B, editors. Basic & clinical biostatistics, 4th edn. New York, NY : McGraw-Hill Medical, 2004 : 118.
10. Alderson P, Green S Cochrane Collaboration open learning material for reviewers. Version 1.1, 2002. Available at: http://www.cochrane.org. Accessed September 10, 2005.
11. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996 17 : 1 12.
12. Moher D, Cook DJ, Jadad AR, Tugwell P, Moher M, Jones A et al. Assessing the quality of randomized controlled trials: implications for the conduct of meta-analyses. Health Technol Assess 1999 3 : 12.
13. Moher D, Jadad A, Nichol G, Penman M, Tugwell T, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 1995 16 : 62 73.
14. Alderson P, Green S Cochrane Collaboration open learning material for reviewers. Version 1.1, 2002. Available at: http://www.cochrane.org. Accessed September 10, 2005.
15. Deeks JJ, Altman D, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In : Egger M, Davey Smith G, Altman DG, editors. Systematic reviews in health care. London, UK : BMJ Publishing, 2001 : 285 312.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003 327 : 557 560.
17. RevMan 4.2.7 program [computer program]. Oxford, England : Cochrane Collaboration, 2004.
18. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double blind study. Allergol Immunopathol 1990 18 : 277 284.
19. Hirsch T, Sahn M, Leupold W. Double blind placebo controlled study of sublingual immunotherapy with house dust mite extracts in children. Pediatr Allergy Immunol 1997 8 : 21 27.
20. Passalacqua G, Albano M, Fregonese L, Riccio A, Pronzato C, Mela GS et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite induced rhinoconjunctivitis. Lancet 1998 351 : 629 632.
21. Guez S, Vatrinet C, Fadel R, Andre' C. House dust mite sublingual swallow immunotherapy in perennial rhinitis: a double blind placebo controlled study. Allergy 2000 55 : 369 375.
22. Bahcecilier NN, Isik U, Barlan IB, Basaran N. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol 2001 32 : 49 55.
23. Ippoliti F, De Sanctis W, Volterrani A, Lenti L, Canitano N, Lucarelli S et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003 14 : 216 221.
24. Tonnel AB, Scherpereel A, Douay B, Mellin B, Leprince D, Goldstein N et al. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Allergy 2004 59 : 491 497.
25. Passalacqua G, Pasquali M, Ariano R, Lombardi C, Baiardini I, Majani G et al. Randomized double-blind controlled study with sublingual carbamylated allergoid immunotherapy in mild rhinitis due to mites. Allergy 2006 61 : 849 854.
26. Bousquet J, Scheinmann P, Guinnepain MT, Perrin-Fayolle M, Sauvaget J, Tonnel AB et al. Sublingual swallow immunotherapy (SLIT) in patients with asthma due to house dust mites: a double blind placebo controlled study. Allergy 1999 54 : 249 260.
27. Pajno GB, Morabito L, Barberio G, Parmiani S. Clinical and immunological effects of longterm sublingual immunotherapy in asthmatic children sensitized to mite: a double blind study. Allergy 2000 55 : 842 849.
28. Niu CK, Chen WY, Huang JL, Lue KH, Wang JY. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan. Respir Med 2006 100 : 1374 1383.
29. Lue KH, Lin YH, Sun HL, Lu KH, Hsieh JC, Chou MC. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study. Pediatr Allergy Immunol 2006 17 : 408 415.
30. Pham-Thi N, Scheinmann P, Fadel R, Combebias A, Andre C. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. Pediatr Allergy Immunol 2007 18 : 47 57.
31. Alderson P, Green S, Higgins JPT Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]. In : Alderson P, Green S, Higgins JPT, editors The Cochrane Library, Issue 1, 2004. Chichester, UK : John Wiley & Sons, Ltd.
32. Dickersin K, Scherer R, Lefebvre C. Systematic Reviews: Identifying relevant studies for systematic reviews. BMJ 1994 309 : 1286 1291.
33. Moher D, Horsley T, Morgan K, Tricco A, Tsertsvadze A. Blinded versus unblinded assessments of risk-of-bias in studies included in a systematic review (Protocol). Cochrane Database Syst Rev 2007, Issue 4, Art. No.: MR000025. DOI:.
34. Canonica GW, Baena-Cagnani CE, Bousquet J, Bousquet PJ, Lockey RF, Malling HJ et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 2007 62 : 317 324.